Literature DB >> 10910141

Analysis of 4070A envelope levels in retroviral preparations and effect on target cell transduction efficiency.

J H Slingsby1, D Baban, J Sutton, M Esapa, T Price, S M Kingsman, A J Kingsman, A Slade.   

Abstract

A number of stable producer cell lines for high-titer Mo-MuLV vectors have been constructed. Development has previously centered on increasing end-point titers by producing maximal levels of Mo-MuLV Gag/Pol, envelope glycoproteins, and retroviral RNA genomes. We describe the production yields and transduction efficiency characteristics of two Mo-MuLV packaging cell lines, FLYA13 and TEFLYA. Although they both produce 4070A-pseudotyped retroviral vectors reproducibly at >1 x 10(6) LFU ml(-1), the transduction efficiency of unconcentrated and concentrated virus from FLYA13 lines is poor compared with vector preparations from TEFLYA lines. A powerful inhibitor of retroviral transduction is secreted by FLYA13 packaging cells. We show that the inhibitory factor does not affect transduction of target cells by RD114-pseudotyped vectors. This suggests that the inhibitory factor functions at the level of envelope-receptor interactions. Phosphate starvation of target cells shows a two-fold increase in Pit2 receptor mRNA and causes some improvement in FLYA13 virus transduction efficiency. Western blots show that FLYA13 viral samples contain an eight-fold higher ratio of 4070A envelope to p30gag than that of virus produced by TEFLYA producer cell lines. This study correlates overexpression of 4070A envelope glycoprotein in retroviral preparations with a reduction of transduction efficiency at high multiplicities of infection. We suggest that TEFLYA packaging cells express preferable levels of 4070A compared with FLYA13, which not only enables high-titer stocks to be generated, but also facilitates a high efficiency of transduction of target cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10910141     DOI: 10.1089/10430340050057512

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  9 in total

1.  Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein.

Authors:  D Lavillette; B Boson; S J Russell; F L Cosset
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein.

Authors:  Toshie Sakuma; Suk See De Ravin; Jason M Tonne; Tayaramma Thatava; Seiga Ohmine; Yasuhiro Takeuchi; Harry L Malech; Yasuhiro Ikeda
Journal:  Hum Gene Ther       Date:  2010-09-17       Impact factor: 5.695

3.  Transduction efficiency of pantropic retroviral vectors is controlled by the envelope plasmid to vector plasmid ratio.

Authors:  Yong Chen; William M Miller; Ashok Aiyar
Journal:  Biotechnol Prog       Date:  2005 Jan-Feb

4.  Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastoma.

Authors:  Juraj Hlavaty; Gerrit Jandl; Melissa Liszt; Helga Petznek; Marielle König-Schuster; Jenny Sedlak; Monika Egerbacher; Jakob Weissenberger; Brian Salmons; Walter H Günzburg; Matthias Renner
Journal:  J Neurooncol       Date:  2010-07-11       Impact factor: 4.130

5.  Primary attachment of murine leukaemia virus vector mediated by particle-associated heparan sulfate proteoglycan.

Authors:  Nina Kureishy; Daisy Faruque; Colin D Porter
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

6.  Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus.

Authors:  Christoph A Kahl; Jon Marsh; Joanne Fyffe; David A Sanders; Kenneth Cornetta
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  Efficient human hematopoietic cell transduction using RD114- and GALV-pseudotyped retroviral vectors produced in suspension and serum-free media.

Authors:  Karim Ghani; Xiuyan Wang; Pedro Otavio de Campos-Lima; Malgorzata Olszewska; Amine Kamen; Isabelle Rivière; Manuel Caruso
Journal:  Hum Gene Ther       Date:  2009-09       Impact factor: 5.695

8.  Overexpression of connexin 43 using a retroviral vector improves electrical coupling of skeletal myoblasts with cardiac myocytes in vitro.

Authors:  Oleg Tolmachov; Yu-Ling Ma; Michael Themis; Pravina Patel; Hilmar Spohr; Kenneth T Macleod; Nina D Ullrich; Yvonne Kienast; Charles Coutelle; Nicholas S Peters
Journal:  BMC Cardiovasc Disord       Date:  2006-06-06       Impact factor: 2.298

Review 9.  Downstream processing of cell culture-derived virus particles.

Authors:  Michael W Wolf; Udo Reichl
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.